Showing results (71-80 of 104) with videos related to
Sort By:
Pageof 11
Cancer Immunology, Immunotherapy : CII|April 23, 2013
Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulinShivani Srivastava, David Pelloso, Hailin Feng, et al.Stem Cells and Development|December 29, 2012
In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignanciesSherif S Farag, Shivani Srivastava, Steven Messina-Graham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphomaArnold Freedman, Sattva S Neelapu, Craig Nichols, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2010
A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory non-Hodgkin lymphomaShivani Srivastava, David Jones, Lisa L Wood, et al.American Journal of Hematology|October 28, 2014
Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemiaMuhammad Rizwan Khawaja, Susan M Perkins, Jennifer E Schwartz, et al.Nature|February 7, 2024
Allosteric modulation and G-protein selectivity of the Ca2+-sensing receptorFeng He, Cheng-Guo Wu, Yang Gao, et al.Nature|July 1, 2021
Asymmetric activation of the calcium-sensing receptor homodimerYang Gao, Michael J Robertson, Sabrina N Rahman, et al.Nature Communications|May 10, 2023
Structural basis for activation of CB1 by an endocannabinoid analogKaavya Krishna Kumar, Michael J Robertson, Elina Thadhani, et al.Cell|September 18, 2020
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorKuglae Kim, Tao Che, Ouliana Panova, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's diseaseAnas Younes, Barbara Pro, Michael J Robertson, et al.Pageof 11